USBC Finalizes Strategic Partnership Agreement with Uphold
USBC announced that it has finalized the terms of its strategic business partnership with Uphold, the infrastructure provider for on-chain finance and nationally-chartered Vast Bank. The parties expect the agreement to potentially support a wide range of use cases for tokenized deposits, including faster settlement, improved treasury operations, and new digital asset services for institutional and retail clients, subject to applicable regulatory approvals and technical milestones. The definitive triparty agreement formalizes the memorandum of understanding signed by USBC, Vast Bank and Uphold in October 2025.
Trade with 70% Backtested Accuracy
Analyst Views on USBC
About USBC
About the author

- Stake Increase: Pyu Pyu Capital disclosed a 19.99% stake in Biomx Inc through a 13D filing, causing the company's shares to surge 103.4% to $8.34 in pre-market trading, indicating strong market confidence in its future prospects.
- Market Reaction: The dramatic rise in Biomx Inc's stock price reflects optimistic investor expectations regarding its potential growth opportunities, particularly in the context of strategic transformations within the biotechnology sector, which may attract further investor interest.
- Industry Impact: The significant increase in Biomx Inc's stock price could positively influence other biotechnology companies, enhancing overall market confidence in the sector and potentially leading to increased capital inflows into related fields.
- Investor Sentiment: This substantial stock price increase not only elevates Biomx Inc's market position but may also encourage other companies to adopt similar strategic initiatives to attract investors and enhance their competitive edge.

U.S. Stock Market Performance: U.S. stocks rose, with the Dow Jones gaining approximately 350 points on Friday, driven by strong earnings reports from several companies.
Ford Motor Company Earnings: Ford's shares surged 9.4% to $13.50 after reporting third-quarter earnings of 45 cents per share and revenue of $47.18 billion, both exceeding analyst expectations.
Significant Stock Gains: Inhibrx Biosciences saw a 72.8% increase in shares after positive trial results, while MidWestOne Financial Group gained 30.4% following an acquisition announcement.
Other Notable Performers: Companies like Grindr, Clover Health, and Comfort Systems USA also experienced significant stock price increases, reflecting a generally positive market sentiment.

USBC's Participation in Money20/20: USBC, Inc. will participate in the Money20/20 USA conference from October 26-29, 2025, showcasing its innovative approach to financial technology and tokenized deposits.
Focus on Tokenized Deposits: The company aims to position its tokenized deposits, backed by an OCC-chartered U.S. bank and blockchain technology, as a compliant and programmable digital dollar, offering regulatory protections and interest-bearing accounts.

U.S. Stock Market Trends: U.S. stock futures are down, with the Dow futures dropping over 100 points, indicating a bearish market sentiment.
Notable Stock Movements: Energy Fuels Inc. shares fell 6.4% after announcing a $550 million private offering, while other companies like Epsium Enterprise Limited and JFB Construction Holdings also experienced significant pre-market declines.

U.S. Stock Market Overview: U.S. stocks declined, with the Nasdaq Composite dropping over 100 points on Thursday, while several individual stocks saw significant gains.
Ameresco Stock Surge: Ameresco, Inc. shares rose 10.5% to $34.94 after Jefferies upgraded the stock from Hold to Buy and increased its price target from $19 to $39.
Notable Stock Performances: Lithium Americas Corp. and Kodiak Sciences Inc. experienced substantial increases of 16.8% and 16%, respectively, due to positive news and analyst upgrades.
Other Gainers: Several other companies, including Centrus Energy Corp. and NioCorp Developments Ltd., also saw notable stock price increases, reflecting a generally positive trend for select stocks despite the overall market decline.




